Press release
Macro and Microeconomic Factors Continue to Impact Bacterial Conjunctivitis Market During 2014 - 2020
Conjunctivitis also termed as pink eye in the United States and Madras eyes in India is caused due to infection or inflammation of the transparent membrane that covers the part of eyeball and inner surface of eyelids. The name Madras eye was originated in 20th century when adenovirus was discovered in India. Conjunctivitis is most commonly caused due to viral or bacterial infection, exposure to chemical or irritants or allergic reaction. Allergic conjunctivitis is known to be caused due to allergens such as cosmetic smoke, dust mites, pollen, perfumes and balsam of peru. Blurred vision, redness of eye, sensitivity to light, watering or itching of both the eyes, watery discharge from one or both the eyes and feeling of grittiness in one or both the eyes are the major symptoms witnessed in individuals suffering from conjunctivitis.Report Overview and TOC @ https://www.transparencymarketresearch.com/bacterial-conjunctivitis-market.html
It is a highly contagious disease and is easily spread through sharing of objects like towel and poor washing of hands. The infection can also spread through sneezing or coughing. Thus, kids or adults diagnosed with pink eye are recommended not travel to public places for that period of time. However, conjunctivitis caused due to allergens (caused due to seasonal pollens, cosmetics and perfumes) or chemicals (chemicals, liquids such as furniture polish or bleach) are not contagious. Although, conjunctivitis caused by infections is highly contagious but it does not cause any serious health problem if diagnosed at an early stage. But, if the disease is left untreated then it can lead to permanent vision loss or other serious eye problem. Keratoconjunctivitis is a combination of conjunctivitis and inflammation of cornea while, blepharoconjunctivitis is a combination of inflammation of the cornea and conjunctivitis.
Request brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3771
Bacterial conjunctivitis is one of the major eye problem encountered worldwide and are caused by bacteria’s such as Moraxella and Chlamydia trachomatis. These bacteria’s are responsible for causing persistent conjunctivitis with higher level of redness. Similarly, Staphylococci and Streptococci are witnessed to cause non acute bacterial conjunctivitis. Moreover, bacteria’s such as β-hemolytic streptococci, Neisseria gonorrhoeae and Corynebacterium diphtheriae are other bacterias that are responsible for the production of membranes or psuedomembranes in bacterial conjunctivitis. Most of the cases of bacterial conjunctivitis are acute and self limiting and not a major cause of serious health problem however; due to its high prevalence the infection can have large impact on the society as individuals tend to miss their school or work. Thus, antibiotic, pills, ointment or eyedrops are given to clear the infection. Furthermore, if antibiotics are not showing proper response then swabs for bacterial culture are examined in the laboratories. Generally, fluoroquinolones, macrolides, amynoglycosides, phenicols are prescribed for the treatment of bacterial conjunctivitis. Similarly, tetracyclines or doxycycline are also prescribed for the treatment of infection caused due to Neisseria gonorrhoeae and Chlamydia trachomatis.
For Specific and Customized requirements @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=3771
Conjunctivitis is an extremely common condition with high incidence and low prevalence. The disease can be treated on its own. Hence, exact estimate of epidemlology of this disease is a challenge. However, as per the statistics published by government authority in the U.S approximately 5 million cases of bacterial conjunctivitis are reported due to increasing number of bacterial infections. Moreover, the treatment of disease in the U.S. accounts for approximately USD 589 million annually. It has also been witnessed that out of all the causes of conjunctivitis, bacterial conjunctivitis account for more than 50% of the cases. Thus, rising incidences of bacterial infection would drive the growth of this market.
Allergan, Inc., Merck, Pfizer, Inc., Novartis and others are some of the major players operating in this market segment.
Pre Book full report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=3771<ype=S
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Macro and Microeconomic Factors Continue to Impact Bacterial Conjunctivitis Market During 2014 - 2020 here
News-ID: 839914 • Views: …
More Releases from Transparency Market Research
Global Avocado-based Products Industry Valued at USD 2.5 Billion in 2024; Projec …
The global avocado-based products market(https://www.transparencymarketresearch.com/avocado-based-products-market.html) is gaining strong traction owing to increasing consumer awareness about the health benefits of plant-based and natural foods, coupled with significant advancements in food processing technologies. As per industry estimates, the market was valued at US$ 2.5 Bn in 2024 and is projected to grow at a CAGR of 6.2% from 2025 to 2035, to cross US$ 5.4 Bn by the end of 2035.
Discover Market…
Warehouse Robotics Market Size to Surpass USD 61.8 Billion by 2035 | Growth Fuel …
The global warehouse robotics market (https://www.transparencymarketresearch.com/warehouse-robotics-market.html) is entering a transformative decade, fueled by the accelerating adoption of automation technologies across logistics, retail, and manufacturing sectors. Valued at US$ 11.6 billion in 2024, the market is projected to grow at a CAGR of 13.8% between 2025 and 2035, reaching a staggering US$ 61.8 billion by 2035.
This remarkable growth is driven by rising e-commerce activities, labor shortages, advancements in artificial intelligence (AI),…
Global Manufacturing Execution System (MES) Market to Surpass US$ 51.2 Bn by 203 …
The global Manufacturing Execution System (MES) market is set to experience robust expansion in the coming decade, reflecting the ongoing digital transformation across industries. Valued at US$ 16.9 billion in 2024, the MES market is projected to grow at a CAGR of 10.6% from 2025 to 2035, reaching approximately US$ 51.2 billion by 2035, according to the latest industry analysis.
Manufacturing Execution Systems (MES) are increasingly becoming the digital backbone of…
HVAC Chillers Market Outlook 2035: Energy-Efficient Cooling Systems Driving Stea …
The global HVAC chillers market is on a robust growth trajectory, powered by the world's increasing emphasis on energy efficiency, sustainability, and the modernization of infrastructure. According to recent market intelligence, the HVAC chillers industry, valued at US$ 13.5 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 5.0% between 2025 and 2035, reaching approximately US$ 23.2 billion by the end of 2035.
This upward…
More Releases for Bacterial
Prominent Bacterial Conjunctivitis Market Trend for 2025: Innovative Eye Drops T …
What Are the Projected Growth and Market Size Trends for the Bacterial Conjunctivitis Market?
The bacterial conjunctivitis market has grown steadily, projected to expand from $4.52 billion in 2024 to $4.76 billion in 2025, at a CAGR of 5.3%. Growth factors include rising bacterial infection cases, improved diagnostics, patient education programs, stringent regulatory frameworks, and physician training.
The bacterial conjunctivitis market is projected to grow steadily, reaching $5.54 billion by 2029 at…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
